GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.

Peptides
Michael G MiskellyNils Wierup

Abstract

Roux-en-Y gastric bypass (RYGB) is the most effective treatment for morbid obesity and results in rapid remission of type 2 diabetes (T2D), before significant weight loss occurs. The underlying mechanisms for T2D remission are not fully understood. To gain insight into these mechanisms we used RYGB-operated diabetic GK-rats and Wistar control rats. Twelve adult male Wistar- and twelve adult male GK-rats were subjected to RYGB- or sham-operation. Oral glucose tolerance tests (OGTT) were performed six weeks after surgery. RYGB normalized fasting glucose levels in GK-rats, without affecting fasting insulin levels. In both rat strains, RYGB caused increased postprandial responses in glucose, GLP-1, and GIP. RYGB caused elevated postprandial insulin secretion in Wistar-rats, but had no effect on insulin secretion in GK-rats. In agreement with this, RYGB improved HOMA-IR in GK-rats, but had no effect on HOMA-β. RYGB-operated GK-rats had an increased number of GIP receptor and GLP-1 receptor immunoreactive islet cells, but RYGB had no major effect on beta or alpha cell mass. Furthermore, in RYGB-operated GK-rats, increased Slc5a1, Pck2 and Pfkfb1 and reduced Fasn hepatic mRNA expression was observed. In summary, our data shows that RY...Continue Reading

References

May 1, 1985·The American Journal of Physiology·E IonescuB Jeanrenaud
Oct 1, 1993·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·R Apweiler, P Freund
Sep 1, 1996·The American Journal of Physiology·C F DeaconJ J Holst
Nov 1, 2002·Annals of Surgery·Francesco Rubino, Michel Gagner
Jun 11, 2005·Obesity Surgery·Kusal WickremesekeraRichard S Stubbs
Aug 2, 2005·Cell Metabolism·Manu V ChakravarthyClay F Semenkovich
Apr 13, 2007·Annual Review of Nutrition·Catherine PosticJean Girard
Jul 12, 2007·American Journal of Physiology. Endocrinology and Metabolism·Etto C EringaPieter Sipkema
Apr 24, 2008·The Journal of Clinical Endocrinology and Metabolism·Blandine LaferrèreBlanca Olivan
Feb 1, 2011·IUBMB Life·María L MassaFlavio Francini
Feb 10, 2011·American Journal of Physiology. Endocrinology and Metabolism·Madeleine SpeckTimothy J Kieffer
Jun 20, 2012·Journal of Visualized Experiments : JoVE·Marco BueterCarel W le Roux
Oct 29, 2013·Current Opinion in Pharmacology·Jens Juul Holst
Jan 5, 2014·Cold Spring Harbor Perspectives in Biology·Jérémie BoucherC Ronald Kahn
Jan 17, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jianping YeHans-Rudolf Berthoud
Mar 18, 2013·Journal of Diabetes Investigation·Yutaka Seino, Daisuke Yabe
Oct 12, 2014·Pflügers Archiv : European journal of physiology·Ivana VrhovacHermann Koepsell
Dec 18, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Maria Saur SvaneJens Juul Holst
Oct 16, 2015·The Journal of Endocrinology·Xinrong ZhouCaifeng Yan

❮ Previous
Next ❯

Citations

Sep 10, 2021·Molecular Metabolism·Lena OppenländerHeiko Lickert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Related Papers

Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
Johan BerggrenNils Wierup
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
Konstantinos Spaniolas, Walter J Pories
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
Bing HePing Han
American Journal of Physiology. Endocrinology and Metabolism
J David MosinskiJohn P Kirwan
© 2021 Meta ULC. All rights reserved